Evaluation of Efficacy, Safety and Tolerability of VeraCept IUS
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Turok, MD, MPH
University of Utah
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
41 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Momdoc Women'S Health Research
Scottsdale, Arizona, United States
- Copperstate Ob/gyn Associates
Tucson, Arizona, United States
- Essential Access Health
Berkeley, California, United States
- Essential Access Health
Los Angeles, California, United States
- Empire Clinical Research
Pomona, California, United States
- University of California, Davis Health System
Sacramento, California, United States
- M3 Wake Research (formerly Medical Center for Clinical Research)
San Diego, California, United States
- M3 Wake Research (formerly Women'S Health Care Research)
San Diego, California, United States
- Stanford University, Medical Center, Obstetrics and Gynecolocy
Stanford, California, United States
- Velocity Clinical Research (formerly Downtown Women'S Health Care)
Englewood, Colorado, United States
- Altus Research, Inc
Lake Worth, Florida, United States
- Emory University School of Medicine
Atlanta, Georgia, United States
- Soapstone Center for Clinical Research
Decatur, Georgia, United States
- Clinical Research Prime
Idaho Falls, Idaho, United States
- Women'S Health Advantage
Fort Wayne, Indiana, United States
- Indiana University
Indianapolis, Indiana, United States
- Praetorian Pharmaceutical Research
Marrero, Louisiana, United States
- University of Michigan Von Voigtlander Women'S Hospital
Ann Arbor, Michigan, United States
- Planned Parenthood North Central States - Minneapolis
Minneapolis, Minnesota, United States
- Planned Parenthood Great Rivers (formerly Planned Parenthood of the St. Louis Region and Southwest Missouri)
Manchester, Missouri, United States
- Rex Garn Mabey Jr., Md
Las Vegas, Nevada, United States
- Capital Health Lawrence Obgyn Research (formerly Lawrence Ob/gyn Clinical Research)
Lawrenceville, New Jersey, United States
- Columbia University Medical Center, Division of Family Planning
New York, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- University of Cincinnati/reproductive Medicine Research
Cincinnati, Ohio, United States
- the Ohio State University Ob/gyn Research Office
Columbus, Ohio, United States
- Ohsu Women'S Health Research Unit
Portland, Oregon, United States
- Clinical Research of Philadelphia
Philadelphia, Pennsylvania, United States
- University of Pennsylvania/penn Family Planning and Pregnancy Loss Center
Philadelphia, Pennsylvania, United States
- Magee-Womens Hospital, Center for Family Planning Research
Pittsburgh, Pennsylvania, United States
- Medical Research South, Llc
Charleston, South Carolina, United States
- Chattanooga Medical Research
Chattanooga, Tennessee, United States
- the Jackson Clinic, Pa
Jackson, Tennessee, United States
- Advanced Research Associates
Corpus Christi, Texas, United States
- Advances in Health
Pearland, Texas, United States
- University of Utah Healthcare Health Sciences Center
Salt Lake City, Utah, United States
- Wasatch Clinical Research
Salt Lake City, Utah, United States
- Eastern Virginia Medical
Norfolk, Virginia, United States
- Tidewater Physicians for Women
Norfolk, Virginia, United States
- Seattle Clinical Research Center (formerly Seattle Women'S Health)
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 22 Aug 2018
- Primary completion
- 22 Sept 2022
- Completion
- 22 Sept 2027
- Last update posted
- 22 Aug 2025
- Registered enrollment
- 1,620
- Registry id
- NCT03633799
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.